Drawing for SEVER PHARMA SOLUTIONS

USPTO serial 79324831

SEVER PHARMA SOLUTIONS

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
MESSICK, TABITHA LEE
Law office
TTAB

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SEVER PHARMA SOLUTIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

RICHARD E PARKE

RICHARD E PARKE WISSING MILLER LLP31 HUDSON YARDS 11TH FLOORINDUSTRIOUS AT HUDSON YARDSNEW YORK, NY 10001

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals, medical and veterinary preparations, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; plasters for medical purposes, materials for dressings being medical dressings; medical plasters; material for stopping teeth, dental waxABANDONED—
010Surgical apparatus and instruments; Surgical apparatus and instruments for medical, dental or veterinary useABANDONED—
035Wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical suppliesABANDONED—
042Providing medical and scientific research information about the results of clinical trials for pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; scientific research in the nature of conducting clinical trials for pharmaceutical products for others; development of pharmaceutical preparations and medicines; pharmaceutical products development; research on the subject of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical research services; medical researchABANDONED—
044Medical consultations; medical counseling; medical information; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; nursing, medical; Pharmaceutical compounding services; provision of pharmaceutical medical information; Pharmaceutical adviceABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 30, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jun 30, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Jun 6, 2024MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Jun 6, 2024ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Jun 6, 2024OP.TOPPOSITION TERMINATED NO. 999999—
Jun 6, 2024OP.SOPPOSITION SUSTAINED NO. 999999—
Oct 21, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 24, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 5, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 5, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 21, 2023RFNTREFUSAL PROCESSED BY IB—
Feb 22, 2023OP.IOPPOSITION INSTITUTED NO. 999999—
Feb 21, 2023OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Feb 21, 2023OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Feb 13, 2023CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Feb 13, 2023APETASSIGNED TO PETITION STAFF—
Feb 1, 2023EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Dec 2, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 2, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 2, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 1, 2022WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Dec 1, 2022WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Nov 7, 2022ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 25, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 25, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 5, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 19, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 8, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 8, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 8, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 13, 2022RFNTREFUSAL PROCESSED BY IB—
Jun 23, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 23, 2022RFRRREFUSAL PROCESSED BY MPU—
May 31, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 30, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2022DOCKASSIGNED TO EXAMINER—
Nov 12, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 8, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 4, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance